Seattle—While antiretroviral drugs have done much to extend the lives of people infected with HIV, severe adverse effects and rising levels of drug resistance can limit their usefulness and are driving efforts to develop new anti-HIV medications. Building on knowledge of HIV gleaned from laboratory studies of the virus, researchers are developing and testing a host of promising new anti-HIV agents, according to findings unveiled here at the Ninth Annual Retrovirus Conference.
Stephenson J. Researchers Explore New Anti-HIV Agents. JAMA. 2002;287(13):1635-1637. doi:10.1001/jama.287.13.1635